BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 27226198)

  • 1. Insulin and Lispro Insulin: What is Common and Different in their Behavior?
    Selivanova OM; Suvorina MY; Surin AK; Dovidchenko NV; Galzitskaya OV
    Curr Protein Pept Sci; 2017; 18(1):57-64. PubMed ID: 27226198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to determine the size of folding nuclei of protofibrils from the concentration dependence of the rate and lag-time of aggregation. II. Experimental application for insulin and LysPro insulin: aggregation morphology, kinetics, and sizes of nuclei.
    Selivanova OM; Suvorina MY; Dovidchenko NV; Eliseeva IA; Surin AK; Finkelstein AV; Schmatchenko VV; Galzitskaya OV
    J Phys Chem B; 2014 Feb; 118(5):1198-206. PubMed ID: 24428561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of amyloid core regions of insulin analogues fibrils.
    Surin AK; Grishin SY; Galzitskaya OV
    Prion; 2020 Jan; 14(1):149-162. PubMed ID: 32543316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural model of amyloid fibrils for amyloidogenic peptide from Bgl2p-glucantransferase of S. cerevisiae cell wall and its modifying analog. New morphology of amyloid fibrils.
    Selivanova OM; Glyakina AV; Gorbunova EY; Mustaeva LG; Suvorina MY; Grigorashvili EI; Nikulin AD; Dovidchenko NV; Rekstina VV; Kalebina TS; Surin AK; Galzitskaya OV
    Biochim Biophys Acta; 2016 Nov; 1864(11):1489-99. PubMed ID: 27500912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular mechanism of amyloid formation by Ab peptide: review of own works].
    Selivanova OM; Rogachevsky VV; Syrin AK; Galzitskaya OV
    Biomed Khim; 2018 Jan; 64(1):94-109. PubMed ID: 29460839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual effect of non-ionic detergent Triton X-100 on insulin amyloid formation.
    Siposova K; Sedlak E; Kozar T; Nemergut M; Musatov A
    Colloids Surf B Biointerfaces; 2019 Jan; 173():709-718. PubMed ID: 30384267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gallic acid oxidation products alter the formation pathway of insulin amyloid fibrils.
    Sakalauskas A; Ziaunys M; Smirnovas V
    Sci Rep; 2020 Sep; 10(1):14466. PubMed ID: 32879381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of insulin amyloid fibrillation by Morin hydrate.
    Patel P; Parmar K; Das M
    Int J Biol Macromol; 2018 Mar; 108():225-239. PubMed ID: 29197568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic species in amyloid-associated diseases: Oligomers or mature fibrils.
    Siddiqi MK; Malik S; Majid N; Alam P; Khan RH
    Adv Protein Chem Struct Biol; 2019; 118():333-369. PubMed ID: 31928731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of binding of macrocyclic metal complexes on amyloid fibrillization of insulin and lysozyme.
    Kovalska V; Chernii S; Cherepanov V; Losytskyy M; Chernii V; Varzatskii O; Naumovets A; Yarmoluk S
    J Mol Recognit; 2017 Aug; 30(8):. PubMed ID: 28295701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-inhibition of insulin amyloid-like aggregation.
    Ziaunys M; Sneideris T; Smirnovas V
    Phys Chem Chem Phys; 2018 Nov; 20(43):27638-27645. PubMed ID: 30374505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A hydrophobic low-complexity region regulates aggregation of the yeast pyruvate kinase Cdc19 into amyloid-like aggregates
    Grignaschi E; Cereghetti G; Grigolato F; Kopp MRG; Caimi S; Faltova L; Saad S; Peter M; Arosio P
    J Biol Chem; 2018 Jul; 293(29):11424-11432. PubMed ID: 29853641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid Oligomers, Protofibrils and Fibrils.
    Siddiqi MK; Majid N; Malik S; Alam P; Khan RH
    Subcell Biochem; 2019; 93():471-503. PubMed ID: 31939162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural characterization and biological properties of the amyloidogenic elastin-like peptide (VGGVG)3.
    Moscarelli P; Boraldi F; Bochicchio B; Pepe A; Salvi AM; Quaglino D
    Matrix Biol; 2014 Jun; 36():15-27. PubMed ID: 24686253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early mechanisms of amyloid fibril nucleation in model and disease-related proteins.
    Morel B; Conejero-Lara F
    Biochim Biophys Acta Proteins Proteom; 2019 Nov; 1867(11):140264. PubMed ID: 31437584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of Protein Amyloid-Like Aggregates by Solid-State Circular Dichroism Spectroscopy.
    Hu HY; Jiang LL; Hong JY
    Curr Protein Pept Sci; 2017; 18(1):100-103. PubMed ID: 27396751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural polymorphism and possible pathways of amyloid fibril formation on the example of insulin protein.
    Selivanova OM; Galzitskaya OV
    Biochemistry (Mosc); 2012 Nov; 77(11):1237-47. PubMed ID: 23240561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysozyme Fibrils Alter the Mechanism of Insulin Amyloid Aggregation.
    Ziaunys M; Sakalauskas A; Sneideris T; Smirnovas V
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33579016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Investigation of the kinetics of insulin amyloid fibrils formation].
    Sulatskaia AI; Volova EA; Komissarchik IaIu; Snigirevskaia ES; Maskevich AA; Drobchenko EA; Kuznetsova IM; Turoverov KK
    Tsitologiia; 2013; 55(11):809-14. PubMed ID: 25509136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and intermolecular dynamics of aggregates populated during amyloid fibril formation studied by hydrogen/deuterium exchange.
    Carulla N; Zhou M; Giralt E; Robinson CV; Dobson CM
    Acc Chem Res; 2010 Aug; 43(8):1072-9. PubMed ID: 20557067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.